CEO and Chairman of the BOD @ Tetherex Pharmaceuticals (June 2013 - Present)
President and CEO @ Selexys Pharmaceuticals (Sold to Novartis for $665M) (March 2008 - November 2016)
Cofounder and Senior Vice President @ (April 1992 - February 2008)
Scott Rollins Education
Yale University
Postdoctoral (Molecular Immunology)
1990-1992
University of Oklahoma College of Medicine
Ph.D (Microbiology / Immunology)
1986-1990
Scott Rollins Skills
Technology Transfer
R&d
Sales
Social Media
Medical Writing
Startups
Pharmaceutical Industry
Large Enterprise
Oncology
Hematology
Biotechnology
Molecular Biology
Lifesciences
Drug Development
Commercialization
FDA
Clinical Trials
New Business Development
Clinical Research
Biopharmaceuticals
Clinical Development
Drug Discovery
Immunology
Team Building
Dermatology
Strategy
Scott Rollins Summary
Scott Rollins, based in Oklahoma City, OK, US, is currently a CEO and Chairman of the BOD at Tetherex Pharmaceuticals. Scott Rollins brings experience from previous roles at Moat Biotechnology, Selexys Pharmaceuticals (Sold to Novartis for $665M) and Alexion Pharmaceuticals, Inc.. Scott Rollins holds a 1990 - 1992 Postdoctoral in Molecular Immunology @ Yale University. With a robust skill set that includes Technology Transfer, R&d, Sales, Social Media, Medical Writing and more. Scott Rollins has 1 mobile phone numbers on RocketReach.
Looking for a different Scott Rollins?
Find contact details for 700 million professionals.